Gossamer Bio Inc (NASDAQ:GOSS) has a beta value of 1.91 and has seen 1.2 million shares traded in the recent trading session. The company, currently valued at $326.18M, closed the recent trade at $1.43 per share which meant it gained $0.07 on the day or 5.51% during that session. The GOSS stock price is -8.39% off its 52-week high price of $1.55 and 53.85% above the 52-week low of $0.66. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.77 million shares traded. The 3-month trading volume is 1.87 million shares.
The consensus among analysts is that Gossamer Bio Inc (GOSS) is Buy stock at the moment, with a recommendation rating of 1.40. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 3 out of 10 have rated it as a Hold, with 7 advising it as a Buy. 0 have rated the stock as Underweight.
Gossamer Bio Inc (NASDAQ:GOSS) trade information
Sporting 5.51% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the GOSS stock price touched $1.43 or saw a rise of 5.3%. Year-to-date, Gossamer Bio Inc shares have moved 22.65%, while the 5-day performance has seen it change 14.80%. Over the past 30 days, the shares of Gossamer Bio Inc (NASDAQ:GOSS) have changed 11.24%. Short interest in the company has seen 11.08 million shares shorted with days to cover at 7.56.
Wall Street analysts have a consensus price target for the stock at $4, which means that the shares’ value could jump 64.25% from the levels at last check today.. The projected low price target is $2.0 while the price target rests at a high of $5.0. In that case, then, we find that the latest price level in today’s session is -249.65% off the targeted high while a plunge would see the stock gain -39.86% from the levels at last check today..
Gossamer Bio Inc (GOSS) estimates and forecasts
The company’s shares have gained 36.67% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 40.29% over the past 5 years. Earnings growth for 2025 is a modest -169.82% while over the next 5 years, the company’s earnings are expected to increase by 15.97%.
GOSS Dividends
Gossamer Bio Inc is expected to release its next earnings report on 2025-May-15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Gossamer Bio Inc (NASDAQ:GOSS)’s Major holders
Insiders own 3.51% of the company shares, while shares held by institutions stand at 75.98% with a share float percentage of 78.74%. Investors are also buoyed by the number of investors in a company, with Gossamer Bio Inc having a total of 142.0 institutions that hold shares in the company. The top two institutional holders are NEA MANAGEMENT COMPANY, LLC with over 18.09 million shares worth more than $16.3 million. As of 2024-06-30, NEA MANAGEMENT COMPANY, LLC held 7.9979% of shares outstanding.
The other major institutional holder is ARTAL GROUP S.A., with the holding of over 13.31 million shares as of 2024-06-30. The firm’s total holdings are worth over $11.99 million and represent 5.8832% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Select Portfolios-Biotechnology Portfolio and VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund . As of May 31, 2025 , the former fund manager holds about 3.33% shares in the company for having 7.57 shares of worth $11.07 million while later fund manager owns 6.76 shares of worth $9.88 million as of Mar 31, 2025 , which makes it owner of about 2.98% of company’s outstanding stock.
